Inflammatory Astrocytes in ALS

Inflammatory Astrocytes in ALS

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Inflammatory Astrocytes in ALS</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0009002](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0009002)</td>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0009002](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0009002)</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Target</td>
</tr>
<tr>
<td class="label">Anti-inflammatory drugs</td>
<td>NF-κB, cytokines</td>
</tr>
<tr>
<td class="label">GLT-1 enhancement</td>
<td>Glutamate transport</td>
</tr>
<tr>
<td class="label">A1 to A2 reprogramming</td>
<td>Phenotype conversion</td>
</tr>
<tr>
<td class="label">Astrocyte transplantation</td>
<td>Cell replacement</td>
</tr>
</table>

Introduction

Inflammatory astrocytes in amyotrophic lateral sclerosis (ALS) represent a specialized reactive astrocyte phenotype that contributes to motor neuron degeneration. These cells are characterized by a neurotoxic "A1" profile that promotes inflammation and fails to provide necessary support to motor neurons[@ilieva2019].

Inflammatory Astrocytes in ALS

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Inflammatory Astrocytes in ALS</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0009002](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0009002)</td>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0009002](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0009002)</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Target</td>
</tr>
<tr>
<td class="label">Anti-inflammatory drugs</td>
<td>NF-κB, cytokines</td>
</tr>
<tr>
<td class="label">GLT-1 enhancement</td>
<td>Glutamate transport</td>
</tr>
<tr>
<td class="label">A1 to A2 reprogramming</td>
<td>Phenotype conversion</td>
</tr>
<tr>
<td class="label">Astrocyte transplantation</td>
<td>Cell replacement</td>
</tr>
</table>

Introduction

Inflammatory astrocytes in amyotrophic lateral sclerosis (ALS) represent a specialized reactive astrocyte phenotype that contributes to motor neuron degeneration. These cells are characterized by a neurotoxic "A1" profile that promotes inflammation and fails to provide necessary support to motor neurons[@ilieva2019].

The recognition of inflammatory astrocytes as key drivers of ALS pathogenesis has fundamentally changed our understanding of disease mechanisms. Rather than being passive responders to motor neuron injury, these astrocytes actively contribute to neurodegeneration through the secretion of toxic factors and loss of protective functions.

Overview

Inflammatory astrocytes in amyotrophic lateral sclerosis (ALS) represent a specialized reactive astrocyte phenotype that contributes to motor neuron degeneration. These cells are characterized by a neurotoxic profile that promotes inflammation and fails to provide necessary support to motor neurons.
<!-- taxonomy-enrichment -->

<!-- multi-taxonomy-enrichment -->

Multi-Taxonomy Classification

Taxonomy Database Cross-References

PanglaoDB Marker Cross-References

• Unknown (PanglaoDB):

External Database Links

• [Cell Ontology (CL:0009002)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0009002)
• [OBO Foundry (CL:0009002)](http://purl.obolibrary.org/obo/CL_0009002)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [Human Cell Atlas](https://www.humancellatlas.org/)
• [PanglaoDB](https://panglaodb.se/)

Taxonomy & Classification

PanglaoDB Marker Cross-References

• Unknown (PanglaoDB):

External Database Links

• [Cell Ontology (CL:0009002)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0009002)
• [OBO Foundry (CL:0009002)](http://purl.obolibrary.org/obo/CL_0009002)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [PanglaoDB](https://panglaodb.se/)

Pathological Features

Morphological Changes

• Hypertrophic cell bodies
• Increased GFAP expression
• Proliferation in spinal cord and motor cortex
• Association with motor neuron loss

Molecular Markers

The "A1" reactive astrocyte signature includes[@liddelow2017]:

• GFAP - Upregulated intermediate filament
• C3 - Complement component C3 (A1 marker)
• Serpina3n - Acute phase protein
• Lcn2 - Lipocalin-2 (pro-inflammatory)
• Cxcl10 - Chemokine (IP-10)

Mechanisms of Toxicity

Secreted Factors

Dysfunctional Support

• Reduced glutamate clearance (GLT-1 downregulation)
• Impaired potassium buffering
• Decreased metabolic support
• Reduced neurotrophic factor secretion

Excitotoxicity

The primary mechanism of astrocyte-mediated toxicity in ALS:

• GLT-1 (EAAT2) downregulation: Reduced glutamate uptake
• Elevated extracellular glutamate: Motor neuron excitotoxicity
• AMPA/kainate receptor overactivation: Calcium influx
• Cell death: Programmed necrosis and apoptosis

Disease Context

Sporadic ALS

• Most common form (~90-95% of cases)
• Reactive astrocytes cluster around remaining motor neurons
• Variable A1/A2 polarization
• Variable inflammatory profiles across patients

Familial ALS

SOD1 Mutations

• Strong astrocyte involvement in pathogenesis
• Mutant SOD1 secreted by astrocytes
• Non-cell autonomous toxicity to motor neurons
• Well-characterized mouse models

C9orf72 Expansion

• DPR (dipeptide repeat) toxicity in astrocytes
• RNA foci formation
• Stress granule accumulation
• Impaired proteostasis

FUS Mutations

• RNA metabolism disruption
• Mislocalized FUS protein
• Altered transcriptional regulation

TDP-43 Pathology

• Ubiquitin dysfunction
• Aggregate formation
• Autophagy impairment

Astrocyte-Neuron Interaction

Direct Effects

• Physical contact with motor neurons
• Synapse elimination via complement
• Direct毒性因子分泌

Extracellular Vesicles

• Exosome-mediated toxicity
• Transfer of mutant proteins
• microRNA dysregulation

Metabolic Coupling

• Disrupted lactate shuttle
• Impaired ATP transfer
• Mitochondrial dysfunction propagation

Therapeutic Targets

Modulation Strategies

Experimental Approaches

External Links

• ALS Association: [https://www.als.org/](https://www.als.org/)
• Allen Cell Type Atlas: [https://portal.brain-map.org/atlases-and-data/rnaseq](https://portal.brain-map.org/atlases-and-data/rnaseq)
• PubMed: [https://pubmed.ncbi.nlm.nih.gov/](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
• [Cell Types Index](/cell-types) Astrocytes
• [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
• [Motor Neurons](/cell-types/motor-neurons)
• [GFAP](/entities/gfap)
• [Excitotoxicity](/mechanisms/excitotoxicity)
• --

Background

The study of Inflammatory Astrocytes In Als has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.